Medico Remedies (NSE:MEDICO) ROCE %: 48.70% (As of Mar. 2026)


NSE:MEDICO Medico Remedies Ltd NSE:MEDICO
86 GF Score
Price ₹40.28
GF Value ₹75.89
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medico Remedies ROCE %?

Medico Remedies NSE:MEDICO -1.88% 86 ROCE % is 48.70% as of Mar. 2026. GuruFocus rates NSE:MEDICO with a GF Score™ of 86/100 and a GF Value™ of ₹75.89 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medico Remedies's annualized ROCE % for the quarter that ended in Mar. 2026 was 48.70%.

Medico Remedies  (NSE:MEDICO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medico Remedies ROCE % Related Terms

Medico Remedies ROCE % Historical Data

* Premium members only.

The historical data trend for Medico Remedies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies ROCE % Chart

Medico Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.36 25.14 24.18 25.23 28.67

Medico Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.42 17.28 22.16 25.20 48.70
NSE:MEDICO
86GF Score
Medico Remedies Ltd NSE:MEDICO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medico Remedies ROCE % Calculation

Medico Remedies's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=198.659/( ( (1197.993 - 569.615) + (1534.033 - 776.426) )/ 2 )
=198.659/( (628.378+757.607)/ 2 )
=198.659/692.9925
=28.67 %

Medico Remedies's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=368.92/( ( (0 - 0) + (1534.033 - 776.426) )/ 1 )
=368.92/( ( 0 + 757.607 )/ 1 )
=368.92/757.607
=48.70 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 48.70% mean?
Medico Remedies (NSE:MEDICO) has a ROCE % of 48.70% as of Mar. 2026.
Is Medico Remedies' ROCE % too high?
Medico Remedies' current ROCE % is 48.70%. The Drug Manufacturers industry median ROCE % is 7.00. Medico Remedies' value of 48.70% is 596.2% above this industry median. Overall, Medico Remedies has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medico Remedies' ROCE % compare to ZTS?
Medico Remedies' ROCE % of 48.70% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Medico Remedies' value of 48.70% is 596.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medico Remedies's current ROCE % of 48.70% is 596.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medico Remedies's current ROCE % is 48.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medico Remedies stock overvalued right now?
Based on GuruFocus' analysis, Medico Remedies (NSE:MEDICO) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹75.89, compared to a current price of ₹40.28 — trading 46.9% below its estimated fair value. The current ROCE % is 48.70% and 596.2% above the Drug Manufacturers industry median of 7.00. Medico Remedies' overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medico Remedies (NSE:MEDICO), the current ROCE % is 48.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medico Remedies (NSE:MEDICO) Overvalued in 2026?

Based on GuruFocus' analysis, Medico Remedies stock appears to be undervalued. The current stock price of ₹40.28 is trading 46.9% below its estimated GF Value™ of ₹75.89. GuruFocus considers Medico Remedies to be Significantly Undervalued.

Key valuation signals for NSE:MEDICO:

  • ROCE %: 48.70%
  • GF Value™: ₹75.89 vs. price of ₹40.28 (46.9% below fair value)
  • GF Score™: 86/100 with 2 warning signs
  • Industry Position: 596.2% above the Drug Manufacturers median

No single metric tells the full story. See the NSE:MEDICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medico Remedies Business Description

Other Exchanges 540937:India
Address N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
86GF Score

Get the complete analysis for NSE:MEDICO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.28
Price
₹75.89
GF Value